Heart Failure Flashcards

1
Q

How does your body compensate for HFrEF?

A

1) ↑ preload by retaining fluid
2) ↑ SNS
3) Cardiac remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

1) Who gets and ACEi?
2) Why?
3) What else can be added?

A

1) All pts with HF d/t LV systolic dysfunction or any HF w/ low EF
2) start early to stop remodeling
3) diuretic only if fluid retention, can add beta blockers or Dig

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two pathways affected by ACEi and what results?

A
  • ANG I to ANG II is shut off by ACEi –> ↓ vasocxn, ↓ SNS stimulation, and ↓ aldosterone production
  • Breakdown of bradykinins are blocked –> ↑ [bradykinin]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

1) Who should be on a diuretic?

2) Why should diuretics not be used as monotherapy?

A

1) All pts with HF and Fluid Retention

2) ↑ u/o –> ↓ perfusion –> ↑ RAAS = remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What 3 important things does Angiotensin do?

A
  • Vasoconstrictor
  • Activates SNS
  • Causes increased Aldosterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Diuretic Resistance?
What are somethings you can do?
What should you never do?
Best indicator of diuretic efficacy?

A

Def:
- Prolonged rate of absorption resulting in diminished [peak] d/t ↑ tubular Na resorption @ another location
Can do:
- bigger oral or IV doses
- gang up on nephron using combos but use small doses d/t possible pronounced diuresis (use smaller doses)
- ↑ renal blood flow (hard to do)
Not Do:
- NEVER give NSAIDS –> ↓ renal blood flow to nephron
Best Indicator:
- Peak LVLs = diuretic ability in blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

1) What is the goal of HF Diuresis?
2) How much fluid loss should occur?
3) What tells us we’re still within a safe margin?

A
  • Diuresis should not be faster than the movement of fluid from interstitial to intravascular –> HoTN
  • 1 kg of fluid/day; faster than this = Acute Renal Failure
  • < 20:1 BUN:Cr is prerenal azotemia aggressive zone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

1) How does HF –> Hypokalemia?

A

↓CO –> HoTN –> ↓ renal perfusion –> ↑ RAAS –> hyperaldosteronism –> hypokalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MoA of Thiazides in HF?
When to use?
When to not use?

A
MoA: block Na and Cl reabsorb in DCT
- ↓ Na by 5-8%
To use: 
- use early in HF as weak diuretic
Not use: 
- ineffective if GFR <30
- longer use --> ineffective b/c PCT ↑ absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do diuretics treat HF?

What happens if we do this in Pts w/o HF?

A
  • In HF, diuretics ↓ preload w/o compromising CO. In HF, SV not changed much b/c Frank-Starling curve less steep
  • In nml Pts, the same drop in preload –> a large drop in CO which –> symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

4 ways you control HF?

A

1) maintain fluid balance
- decrease sodium,
- add a diuretic
2) improve physical conditioning
3) Rate control in select Pts (A-fib)
4) Avoid CCBs, NSAIDs, and in some cases anti-disrrhythmics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HF –> ↓CO –> Hypotension –> ? (2 branches)

A

1) ↑ Sympathetic tone –> ↑ catecholamines, ↑ vasopressin (ADH)

2) ↓ renal perfusion --> 
              ↑ RAAS
--> ↑ Angiotensin II --> ↑ aldosterone
                 and
-->  ↑ EPI --> ↑HR

(Both) –> vol overload, edema (↑ PCWP), and cardiac remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

3 Therapeutic Strategies for HFrEF

A

1) Remove underlying cause/drives (structural/medical)
2) Remove precipitating cause (infection, arrhythmia, Rx)
3) Control HF State (↑ pump performance, ↓ workload, control excess Na/H2O)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How to improve performance in HF Pts

A

1) symptom mgmt (improve QoL)

2) Prolong Survival (manage cardiac remodeling)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 3 ways to prevent HF?

A

1) Prevent initial injury
2) Prevent further injury
3) Prevent post-injury deterioration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Staging System of HF

- Definition and Key Point

A
  • Where is the Pt in the progress of their HF. Can’t go back up like NYHA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Stage A Heart Failure

A
  • No Sx, no structural changes, but risk of HF

- Risk of HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Stage B Heart Failure

A
  • Fully compensated, asymptomatic, some dmg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Stage C Heart Failure

A
  • Current or prior Sx w/ structural changes
  • “C” for “Classic CHF Pt”
  • No longer fully compensated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Stage D Heart Failure

A
  • Refractory HF w/ special interventions
  • Decompensated
  • Marked Sx @ rest despite med therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

1) Most valuable quantitative measure of HF?
2) Most valuable diagnostic test? - what can it show?
3) What other tests can you do?

A

1) Ejection Fraction
2) Echocardiogram; shows systolic failure from other processes, shows were remodeling occurring, geometric measures
3) Rt heart cath, EEP, BNP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the qualitative evaluations of HF Pts?

A

Functional Testing:
- Exercise testing, QoL survey, peak O2 consumption

Fluid Status:
- BODY WEIGHT, JVD, edema, lung/liver congestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

NYHA Heart Failure Classes

- Definition and 4 key points

A

system based on functional capabilities

  • measure of when we give meds and how we’re doing
  • can go up and down
  • Sx based
  • Slice in time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Class I-IV

A

I - No Sx w/ nml activity
II - Nml activity –> Sx
III - Ok @ rest, ANY activity –> Sx
IV - Sx @ rest, ↑ discomfort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Two Big Goals in HF Mgmt?

A

1) Fix Sx now

2) Prevent HF Later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Mechanism to Improve HF Performance?

A
  • ↑ contractility w/ (+) inotropes
  • ↓ impedence
  • slow/prevent cardiac remodeling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

1) What are the ACEi/ARB Contraindications

2) Relative contraindications that we could still attempt use of ACEi/ARBs with

A

1) previous life threatening rxn and pregnancy

2) SBP < 80 mmHg, Scr > 3mg/dL, Bilat renal artery stenosis, serum K > 5.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

1) How to Start ACEi/ARB and Dosing?
When to reassess?
What drug to start out on?

A

1) Assess fluid status - If vol depleted, w/hold diuretic 24-48 hrs

Start low –> titrate up

  • if risk of hypoTN (LV dysfxn, SBP <100, Na <135) = 6.25mg monitor for 2 hr, then titrate up to starting
  • Elderly (>75 yo) = 12.5 mg q day –> titrate PRN
  • Nml Dose = 12.5 mg TID
  • HTN = 25 mg TID

2) Reassess in 48 hr by phone; back off if dizz/weakness
- Office visit weekly until titrated to target dose

3) Captopril d/t most rapid acting and shortest acting (2hr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What to reassess weekly during ACEi/ARB titration?

A

If any of these are present:

  • Scr ↑ 0.5 mg or more
  • K > 5.5
  • Symptomatic hypoTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is GDMT stand for?

What drugs is GDMT referring to?

A

1) Guideline Directed Medical Therapy

2) 4 ACEi/3 ARBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

4 ACEi and 3 ARBs for HF

A

Captopril
Enalapril
Ramipril
Lisinopril

Candesartan
Losartan
Valsartan

32
Q

Loop Diuretics:

1) MoA
2) Who gets them?
3) Other effects on kidneys

A

1) blocks Na and Cl reabsorption in ascending limb of loop (20-25%)
2) Moderate - severe HF
3) PTG - mediated ↑ in renal blood flow; works in renal insufficiency but may need to ↑ dose

33
Q

What causes angioedema in ACEi reactions?

A

blocks deactivation of bradykinins that –> inflammation

34
Q

1) What’s common if Pt at risk of HoTN and RAAS is activated?
2) What do you do?

A

1) hyponatremia and rapid diuresis

2) Hold diuretics for 1-2 days

35
Q

What are the risks of treatment for ACEi/ARBs

A

1) HypoTN
2) Worsening Renal Fxn
3) K Retention

36
Q

1) What can K retention cause when ACEi are used?
2) What factors ↑ risk of this occurring?
3) How do we manage this?

A

1) can cause heart dysfxn
2) ↓ renal fxn, K supplement, DM
3) equillibriate with diuretic

37
Q

1) What do Beta Blockers do?

A

1) (-) inotrope and (-) chronotrope b/c they block SNS by binding to Beta 1 receptors (some bind alpha receptors)

38
Q

1) Who gets Digoxin?

2) What are the risks?

A

1) HF Pts that are symptomatic (Stage C, Class II/III) and have A-Fib where ALL other therapies maxed
2) Arrhythmias

39
Q

Which HF Pts get Beta Blockers?

What can BBs get added to?

A

1) STABLE class II/III and stage B/C d/t LV systolic dysfxn (EF <35%-40)
2) Preexisting ACEi + Diuretic combo

40
Q

When are Beta Blockers contraindicated?

A
  • bronchospastic dz (asthma)
  • Sx bradycardia (HR < 50)
  • Adv heart block (caution in 2, no in 3)
  • acute decompensated HF
41
Q

What are the 3 Beta Blockers used in HF?

Which BB is different from the others and why?

A

1) carvedilol, bisprolol, metoprolol succinate (SR)

2) carvedilol; the “i” says it’s also an alpha blocker

42
Q

Who gets Bidil?

A

HF adjunct therapy in self-identified black Pts

43
Q

1) Who gets aldosterone antagonists?
2) How do you spell them?
3) What is always a risk with AAs?

A

1) Class IV HF add-on in low doses
2) spironolactone and eplerenone
3) hyperkalemia

44
Q

How to titrate Beta Blockers?

What should you monitor for and do after?

A

1) Double dose q 2-4 weeks if tolerate present dose –> titrate to highest dose
2) bradycardia, hypoTN, fluid retention, worsening HF –> back dose off but do everything to keep them on BB

45
Q

1) When does HoTN typically occur with beta blockers
2) What do you do?
3) What do you not do? Why?

A

1) common w/ carvedilol and in first dose
2) may require temp dose reduction in ACEi, once BP ↑ then ↑ ACEi again
3) Do not ↓ diuretic b/c if you do –> BB will cause fluid retention & worsening HF

46
Q

“Recommended” Means?

A

Thou Shalt

47
Q

Why should calcium antagonists (CCBs) not be used in HF?

A
  • Lack of evidence of efficacy

- (-) inotrope –> safety issues (verapamil = most dangerous CCB)

48
Q

Who gets Hydralazine + Nitrate Combo?
Why typically not used?
Why not used as single drugs?

A

1) HF Pt if ACE/ARB not tolerated and self-identified African American
2) HF Pts cant handle SE
3) Little evidence to suggest benefit when not used in combo

49
Q

Aldosterone Anatagonist Contraindications

A
  • K > 5.5
  • DM 2 with microalbuminuria
  • CrCl < 50
  • Concurrent K-sparring diuretic
50
Q

What is synthetic natruretic peptide (Nesiritide) indicated for?

A

acute decompensated HF

51
Q

(Diagram) Volume Overload leads to?

A
↑ atrial pressure --> ANP release
                and
↑ LV filling --> BNP release
                both lead to
Vasodilation, ↓ sympathetic tone, natruresis and diuresis
                all lead to 
↓ blood volume and ↓ arterial pressure
                that ultimately -->
improved hemodynamics
52
Q

What are the goals when trying to control HF?

A

1) Reduce workload
2) Improve pump performance
3) Reduce Na/H2O Intake

53
Q

When to you actually use (in real life) Thiazides in HF?

A

1) Don’t use in HF

2) Loses effectiveness

54
Q

How to manage Loop Diuretics?

A
  • Titrate to effect, then adjust as needed

- Avoid NSAIDS

55
Q

What are the side effects of Diuretics?

A
  • Hypokalemia
  • Prerenal azotemia
  • HypoTN
56
Q

When do ACEi/ARB show benefit in HF?

A

At target dose –> captopril 50 mg TID

57
Q

What chemicals effect blood flow through the Glomerular apparatus?

A

PTGs –> Afferent Dilation
NSAIDs –> block PTGs –> Afferent Cxn
ANG II –> Efferent Cxn (decreases peritubular pressure –> increased fluid shift back into blood)

58
Q

1) How does aldosterone affect electrolyte balance?

2) What stimulates and decreases aldosterone production?

A

1) Na absorption and H2O retention and elim of K, Mg, and H and simultaneous K uptake by cells
2) Aldosterone release stimulated by hyperkalemia but ↓ by dopamine and ANP

59
Q

What are the two Digoxin doses/parameters?

A

1) Nml dose = 0.25 mg

2) >70 y.o., hepatic/renal dysfxn = 0.125 mg

60
Q

What is important to know about Digoxin monitoring parameters?

A
  • no data suggests an optimal dose or optimal [serum]
  • routine monitoring not required
  • just avoid toxicity
61
Q

What are the ADRs for sprironolactone?

What do you do if Pt reporting hormonal SE?

A

1) HA, dizzy, angina, MI, ↑ GGT

2) Switch to eplerenone

62
Q

1) How do you switch a Pt from an ARB to an ARNI?

2) How do you switch a Pt from an ACEi to an ARNI?

A

1) Stop the ARB, then you can immediately start the ANRI

2) Stop the ACEi, wait for 36 hours, then start the ARNI

63
Q

1) What is an ARNI and what’s in it?

2) Who gets an ARNI?

A

1) ANG-II and Neprilysin Inhibitor, valsartan and sacubitril

2) Class II or III HFrEF that can tolerate an ACEi or ARB

64
Q

What are the ANRI SE?

A

angioedema (valsartan), HoTN/dizzy, impaired renal fxn, hyperkalemia

65
Q

1) What is ivabradine?

2) What drug therapy can it be added to?

A

1) selective SA node inhibitor

2) Beta blockers

66
Q

What are the 5 criteria that must be met to start ivabradine?

A
  • symptomatic chronic stable HF
  • EF < 35%
  • In NSR
  • Resting HR > 70 bpm, despite optimal BB
  • On max tolerated dose of BB
67
Q

What are the contraindications to ivabradine?

A
  • BP sucks
  • Can’t maintain HR
  • Liver doesn’t work
68
Q

ACC/AHA/HFSA Recommendations for Stage A

3 things

A
  • ↓ risk factors
  • Stop doing unhealthy shit
  • Get an echo if needed
  • Start on ACEi/ARB if possible
69
Q

ACC/AHA/HFSA Recommendations for Stage B

4 things

A
  • Treat for remodeling
  • ACEi/ARB/ARNI + BB
  • ARNI for Class II/III
  • No Sx = No Digoxin
70
Q

ACC/AHA/HFSA Recommendations for Stage C

5 things

A
  • Same as A and B recommendations
  • RAAS blocker + Beta blocker
  • Hydralazine + Nitrate OK problems with ACEi/ARB
  • AAs OK with careful monitoring
  • NEVER ACEi + ARB + AA, only 2 of 3
71
Q

Principle 1

A

Target dose = best outcomes

72
Q

Principle 2 - What do you do if you can’t reach target doses?

A

1) Address factors limiting GDMT
If can’t get to target doses then drop AA (if GFR <30 or K > 5.5)
2) Symptomatic HoTN probably d/t overdiuresis or vasoactive Rx

73
Q

Principle 3

A
  • best single drug = BB

- ↓ RAAS blockers if needed

74
Q

Principle 4

A
  • Rate control > 70

- Optimize BB, then add Ivabridine (Corlanor)

75
Q

Principle 5

A

Af Am with Class III –> Hydralazine + ISDN

76
Q

Principle 6

A

Use diuretics to relieve congestion

77
Q

Principle 7

A

Start therapy early, titrate doses